,NASH

Liping Xiang1,2, Xiaoyan Li3, Yunchen Luo4

  • 1Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Life metabolism
|January 28, 2025
PubMed
概括

增长差异化因子3 (GDF3) 是一种非酒精性脂肪肝炎 (NASH) 的非侵入性生物标志物. 这项研究还确定了铁化作为NASH治疗的潜在治疗标.